Eton Pharmaceutcials Inc (ETON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 24,266 | 21,281 | 22,459 | 18,928 | 17,282 |
| Cost of Goods | 9,531 | 8,181 | 14,604 | 7,004 | 7,421 |
| Gross Profit | 14,735 | 13,100 | 7,855 | 11,924 | 9,861 |
| Operating Expenses | 12,852 | 10,817 | 9,822 | 13,403 | 10,752 |
| Operating Income | 2,414 | 2,464 | -1,363 | -1,475 | -470 |
| Interest Expense | 840 | 0 | 592 | 1,044 | 1,028 |
| Other Income | 0 | -1,050 | 0 | 0 | 0 |
| Pre-tax Income | 1,574 | 1,414 | -1,955 | -2,519 | -1,498 |
| Income Tax | 20 | -69 | -28 | 66 | 74 |
| Net Income Continuous | 1,554 | 1,483 | -1,927 | -2,585 | -1,572 |
| Net Income | $1,554 | $1,483 | $-1,927 | $-2,585 | $-1,572 |
| EPS Basic Total Ops | 0.06 | 0.06 | -0.07 | -0.10 | -0.06 |
| EPS Basic Continuous Ops | 0.06 | 0.06 | -0.07 | -0.10 | -0.06 |
| EPS Diluted Total Ops | 0.05 | 0.06 | -0.07 | -0.10 | -0.06 |
| EPS Diluted Continuous Ops | 0.05 | 0.06 | -0.07 | -0.10 | -0.06 |
| EPS Diluted Before Non-Recurring Items | N/A | 0.05 | -0.07 | -0.10 | 0.07 |
| EBITDA(a) | $3,663 | $3,656 | $-175 | $-422 | $837 |